A Comparative Study of KW-2246

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a placebo-controlled, double blind, comparative study to evaluate the efficacy and safety of KW-2246 as rescue medication at an optimal dose, which is determined by dose titration in treating breakthrough pain episodes in adult cancer patients receiving strong opioid analgesic on a fixed-schedule as well as rescue medication for breakthrough pain.
Epistemonikos ID: 0faa68139289c0e7aec41bdb23f2526619d4b169
First added on: May 06, 2024